Novel cardioprotective approaches in ischaemic heart disease

Gemma Vilahur, Monika Radike, Lina Badimon

European Heart Journal, 2024

Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction

Gemma Vilahur, Monika Radike, Pablo Sutelman, Soumaya Ben-Aicha, Manuel Gutiérrez, Laura Casaní, Daniel Hovdal, Emily L Ongstad, Anders Gabrielsen, Alberto Hidalgo, Ola Fjellström, Leif Carlsson, Lina Badimon

European Heart Journal, 2024

Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction

Gemma Vilahur, Soumaya Ben-Aicha, Manuel Gutiérrez, Monika Radike, Guiomar Mendieta, Lisaidy Ramos, Sebastia Alcover, Laura Casani, Gemma Arderiu, Teresa Padró, María Borrell, Lina Badimon

Cardiovascular Research, 2024

Administration of a human recombinant apyrase (AZD3366) limits myocardial tissue injury and improves cardiac function in a pig model of STEMI assessed by serial CMR

Gemma Vilahur, Monika Radike, Pablo Sutelman, Soumaya Ben-Aicha, Manuel Gutierrez, Laura Casani, Guiomar Mendieta, Alberto Hidalgo, O Fjellstrom, L Carlsson, Lina Badimon

European Heart Journal, vol. 43(Supplement 2), 2022

A comprehensive and longitudinal cardiac magnetic resonance imaging study of the impact of coronary ischemia duration on myocardial damage in a highly translatable animal model

Monika Radike, Pablo Sutelman, Soumaya Ben-Aicha, Manuel Gutierrez, Guiomar Mendieta, Sebastia Alcover, Laura Casani, Gema Arderiu, Teresa Padro, Lina Badimon, Gemma Vilahur

European Journal of Clinical Investigation, 2022

Comparison of two cardiac magnetic resonance imaging postprocessing software tools in a pig model of myocardial infarction

Monika Radike, Soumaya Ben-Aicha, Manuel Gutierrez, Alberto Hidalgo, Lina Badimon, Gemma Vilahur

Revista Española de Cardiología (English Edition), 2022

Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration.

G. Mendieta, S. Ben-Aicha, M. Gutierrez, L. Casaní, M. Aržanauskaitė, F. Carreras, M. Sabaté, L. Badimón, G. Vilahur

Journal of the American College of Cardiology, 2020

Ticagrelor in Post-STEMI Adverse Ventricular Remodeling: There Is More Than Meets the Platelet.

G. Vilahur, M. Aržanauskaitė, P. Sutelman

JACC. Cardiovascular interventions, 2020

Administration of a soluble ADPase, AZD3366, on top of ticagrelor confers additional cardioprotective benefits to that of ticagrelor alone

G. Vilahur, M. Aržanauskaitė, P. Sutelman, S. Ben-Aicha, M. Gutierrez, L. Casaní, O. Fjellstrom, L. Carlsson, A. Hidalgo, L. Badimón

2020

HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging–Assessed Atherosclerotic Plaque Burden

S. Ben-Aicha, L. Casaní, Natàlia Muñoz-García, Oriol Joan-Babot, E. Peña, M. Aržanauskaitė, M. Gutierrez, G. Mendieta, T. Padró, L. Badimón, G. Vilahur

Arteriosclerosis, thrombosis, and vascular biology, 2020

P3490Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction

G. Vilahur, S. Ben-Aicha, M. Gutierrez, M. Aržanauskaitė, L. G. Mendieta Badimon, G. Arderiu, L. Casaní, L. Badimón

European Heart Journal, 2019

Intracellular platelet signalling as a target for drug development.

G. Vilahur, M. Gutierrez, M. Aržanauskaitė, G. Mendieta, S. Ben-Aicha, L. Badimón

Vascular pharmacology, 2018